TGFB1 and Myocardial fibrosis: In primary neonatal rat cardiac fibroblasts, high glucose induced myocardial fibrosis via the upregulation of the TGF-β1/Smads pathway, which was promoted by the CaSR agonist R568 but reduced by the CaSR inhibitor Calhex231 [89].